Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation

Critical Care

Volumn 15, Issue 6, 2011, Pages

  Ranucci, Marco ^a   Ballotta, Andrea ^a   Kandil, Hassan ^a   Isgrò, Giuseppe ^a   Carlucci, Concetta ^a   Baryshnikova, Ekaterina ^a   Pistuddi, Valeria ^a  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; FRESH FROZEN PLASMA; HEPARIN; HIRULOG; THROMBOCYTE CONCENTRATE; ANTICOAGULANT AGENT; HIRUDIN DERIVATIVE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ADULT; ANESTHESIA; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EXTRACORPOREAL OXYGENATION; HEART SURGERY; HUMAN; HUMAN CELL; INFANT; INTENSIVE CARE UNIT; NEWBORN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; REACTION TIME; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY; THROMBOEMBOLISM; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; ADOLESCENT; BLOOD CLOTTING; BLOOD TRANSFUSION; CHI SQUARE DISTRIBUTION; CHILD; COMPARATIVE STUDY; FEMALE; MALE; METHODOLOGY; NONPARAMETRIC TEST; STATISTICS;

ADOLESCENT; ADULT; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CHI-SQUARE DISTRIBUTION; CHILD; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEPARIN; HIRUDINS; HUMANS; INFANT; INFANT, NEWBORN; MALE; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 81255128023     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10556     Document Type: Article

References (20)

1. Chen YS, Lin JW, Yu HY, Ko WJ, Jerng JS, Chang WT, Chen WJ, Huang SC, Chi NH, Wang CH, Chen LC, Tsai PR, Wang SS, Hwang JJ, Lin FY. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet 2008, 372:554-561. 10.1016/S0140-6736(08)60958-7, 18603291.
2. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, Hibbert CL, Truesdale A, Clemens F, Cooper N, Firmin RK, Elbourne D, . CESAR Trial Collaboration Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009, 374:1351-1363. 10.1016/S0140-6736(09)61069-2, 19762075, CESAR Trial Collaboration.
3. Smedira NG, Moazami N, Golding CM, McCarthy PM, Apperson-Hansen C, Blackstone EH, Cosgrove DM. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. J Thorac Cardiovasc Surg 2001, 122:92-102. 10.1067/mtc.2001.114351, 11436041.
4. Combes A, Leprince P, Luyt CE, Bonnet N, Trouillet JL, Léger P, Pavie A, Chastre J. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 2008, 36:1404-1411. 10.1097/CCM.0b013e31816f7cf7, 18434909.
5. Leprince P, Combes A, Bonnet N, Ouattara A, Luyt CE, Theodore P, Léger P, Pavie A. Circulatory support for fulminant myocarditis: consideration for implantation, weaning and explantation. Eur J Cardiothorac Surg 2003, 24:399-403. 10.1016/S1010-7940(03)00382-8, 12965311.
6. Polimenakos AC, Wojtyla P, Smith PJ, Rizzo V, Nater M, El Zein CF, Ilbawi MN. Post-cardiotomy extracorporeal cardiopulmonary resuscitation in neonates with complex single ventricle: analysis of outcomes. Eur J Cardiothorac Surg 2011,
7. Bartlett RH, Gattinoni L. Current status of extracorporeal life support (ECMO) for cardiopulmonary failure. Minerva Anestesiol 2010, 76:534-540.
8. Beiras-Fernandez A, Deutsch MA, Kainzinger S, Kaczmarek I, Sodian R, Ueberfuhr P, Meiser B, Schmoeckel M, Reichart B, Brenner P. Extracorporeal membrane oxygenation in 108 patients with low cardiac output - a single-center experience. Int J Artif Organs 2011, 34:365-373. 10.5301/IJAO.2011.7727, 21534247.
9. Warkentin TE, Greinacher A, Koster A. Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required?. Ann Thorac Surg 2009, 87:1633-1640. 10.1016/j.athoracsur.2008.10.060, 19379937.
10. Koster A, Huebler S, Potapov E, Meyer O, Jurmann M, Weng Y, Pasic M, Drews T, Kuppe H, Loebe M, Hetzer R. Impact of heparin-induced thrombocytopenia on outcome in patients with ventricular assist device support: single-institution experience in 358 consecutive patients. Ann Thorac Surg 2007, 83:72-76. 10.1016/j.athoracsur.2006.05.077, 17184633.
11. Oliver WC. Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth 2009, 13:154-175. 10.1177/1089253209347384, 19767408.
12. Weitz JI, Hudoba M, Massel D, Maraganore J, Hirsh J. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III-independent inhibitors. J Clin Invest 1990, 86:385-391. 10.1172/JCI114723, 296739, 2384594.
13. Ranucci M, Isgrò G, Cazzaniga A, Soro G, Menicanti L, Frigiola A. Predictors for heparin resistance in patients undergoing coronary artery bypass grafting. Perfusion 1999, 14:437-442.
14. Barzaghi N, Locatelli A, Ranucci M. Ventricular assist device implantation and the risk for heparin-induced thrombocytopenia. Ann Thorac Surg 2008, 85:360-361. 10.1016/j.athoracsur.2007.06.010, 18154856.
15. Hirsh J, O'Donnel M, Weitz JI. New anticoagulants. Blood 2005, 105:453-463. 10.1182/blood-2003-12-4195, 15191946.
16. Hirsh J, O'Donnell M, Eikelboom JW. Beyond unfractionated heparin and warfarin: current and future advances. Circulation 2007, 116:552-560. 10.1161/CIRCULATIONAHA.106.685974, 17664384.
17. Dyke CM, Smedira NG, Koster A, Aronson S, McCarthy HL, Kirshner R, Lincoff AM, Spiess BD. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study. J Thorac Cardiovasc Surg 2006, 131:533-539. 10.1016/j.jtcvs.2005.09.057, 16515902.
18. Pollak U, Yacobobich J, Tamary H, Dagan O, Manor-Shulman O. Heparin-induced thrombocytopenia and extracorporeal membrane oxygenation: a case report and review of the literature. J Extra Corpor Technol 2011, 43:5-12.
19. Pappalardo F, Maj G, Scandroglio A, Sampietro F, Zangrillo A, Koster A. Bioline heparin-coated ECMO with bivalirudin anticoagulation in a patient with acute heparin-induced thrombocytopenia: the immune reaction appeared to continue unabated. Perfusion 2009, 24:135-137. 10.1177/0267659109106773, 19654158.
20. Koster A, Weng Y, Böttcher W, Gromann T, Kuppe H, Hetzer R. Successful use of bivalirudin as anticoagulant for ECMO in a patient with acute HIT. Ann Thorac Surg 2007, 83:1865-1867. 10.1016/j.athoracsur.2006.11.051, 17462416.